EBOOKS

From Pre-Approval to Post-Launch: End-to-End Commercialization Guide for Specialty Pharma

A practical guide to specialty pharma commercialization: government pricing, patient support programs, specialty pharmacy selection, and post-launch strategy.

Navigating Sunshine Act and State Transparency Requirements

Why companies need to prepare for federal and state transparency requirements long before commercialization

Simulated Advisory Boards:
How to accelerate strategic decision-making in biopharma

Learn how Simulated Advisory Boards create a bridge between internal planning and live clinician engagement. 

The Importance of Quality Activities to REMS Success

How proactive oversight helps prevent operational issues and supports program success.

From Transparency to Prohibition

What Generics Manufacturers Need to Know About the New Drug Price Transparency Landscape

Clarity in Compliance

How to efficiently and accurately plan for and comply with aggregate spend, drug price transparency laws, and government price reporting requirements.

The 0 to 60 Guidebook

After 280+ launches, learn how Two Labs helps emerging manufacturers drive success throughout every step of the commercial journey

280+ Launches Later:
Two Labs' Insights on the Commercialization Journey

Strategic planning, common obstacles, and how emerging manufacturers can give their launch a leg up.

Launch Fundamentals:
The 3PL Selection Process

What you need to know before making one of the most important decisions for your business

Launch Fundamentals:
State Licensing

Avoiding Launch Delays with a Comprehensive State Licensing Strategy

Cell & Gene Therapies

Innovation is the name of the game when it comes to these life- and industry-altering therapies, and manufacturers will need expert guidance to keep pace.